Hair Loss
17
 min read

Hair Loss and Hashimoto's: Causes, Diagnosis, and NHS Treatments

Written by
Bolt Pharmacy
Published on
13/3/2026

Hair loss and Hashimoto's thyroiditis are closely connected, with many people experiencing diffuse shedding as a direct consequence of the autoimmune condition's effect on thyroid hormone levels. Hashimoto's causes the immune system to attack the thyroid gland, leading to hypothyroidism that disrupts the normal hair growth cycle. However, the relationship is rarely straightforward — nutritional deficiencies, over-replacement with levothyroxine, and co-existing autoimmune conditions such as alopecia areata can all contribute. This article explains why hair loss occurs, how it is investigated on the NHS, what treatments are available, and when to seek further medical advice.

Summary: Hair loss in Hashimoto's thyroiditis is most commonly caused by hypothyroidism disrupting the hair growth cycle, though nutritional deficiencies, over-replacement with levothyroxine, and co-existing autoimmune conditions can also contribute.

  • Hashimoto's thyroiditis causes the immune system to attack the thyroid gland, reducing production of T3 and T4 hormones that regulate the hair growth cycle.
  • The resulting hair shedding is typically diffuse telogen effluvium, becoming noticeable two to three months after the hormonal disturbance.
  • Both under-treatment and over-replacement with levothyroxine can cause hair loss; TSH should be rechecked six to eight weeks after any dose change.
  • Low ferritin, vitamin B12 deficiency, and co-existing alopecia areata are common additional causes of hair loss in people with Hashimoto's that require separate investigation.
  • Hair regrowth after optimising thyroid hormone levels can take six to twelve months; high-dose biotin supplements can falsely skew thyroid blood test results.
  • Urgent dermatology review is warranted if scalp pain, redness, pustules, or rapidly progressive hair loss with no regrowth suggest scarring alopecia.

Am I eligible for weight loss injections?

60-second quiz
Eligibility checker

Find out whether you might be eligible!

Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).

  • No commitment — just a quick suitability check
  • Takes about 1 minute to complete

Why Hashimoto's Thyroiditis Can Cause Hair Loss

Hashimoto's reduces thyroid hormone levels, pushing hair follicles prematurely into the resting phase and causing diffuse shedding; both under-treatment and over-replacement with levothyroxine can trigger this effect.

Hashimoto's thyroiditis is an autoimmune condition in which the immune system mistakenly attacks the thyroid gland, gradually impairing its ability to produce sufficient thyroid hormones. The resulting hypothyroidism disrupts numerous physiological processes, including the normal hair growth cycle. Thyroid hormones — primarily thyroxine (T4) and triiodothyronine (T3) — play a critical role in regulating the anagen (growth) phase of hair follicles. When levels fall, follicles may prematurely enter the telogen (resting) phase, leading to diffuse hair shedding known as telogen effluvium. This shedding typically becomes noticeable approximately two to three months after the triggering hormonal disturbance.

Importantly, it is not only hypothyroidism that can cause diffuse hair loss. Hyperthyroidism — including over-replacement with levothyroxine resulting in a suppressed TSH — can equally disrupt the hair growth cycle and lead to increased shedding. If you are taking levothyroxine and notice worsening hair loss alongside symptoms such as palpitations, tremor, heat intolerance, weight loss, or anxiety, this may indicate over-treatment and should prompt a review of your thyroid function.

The hair loss associated with Hashimoto's is typically diffuse rather than patchy, meaning thinning occurs across the entire scalp rather than in isolated areas. Some individuals also notice thinning of the outer third of the eyebrows; whilst this is a recognised feature of hypothyroidism, it is non-specific and should not be used alone to make or exclude a diagnosis. Hair texture may also change, becoming dry, coarse, or brittle, reflecting the broader metabolic slowdown caused by insufficient thyroid hormone.

Beyond the direct hormonal effects, the autoimmune nature of Hashimoto's may independently contribute to hair loss. There is an established association between Hashimoto's and other autoimmune conditions such as alopecia areata, which causes patchy hair loss through a separate immune-mediated mechanism targeting hair follicles directly. It is therefore important not to assume that all hair loss in someone with Hashimoto's is solely thyroid-related, as multiple overlapping causes may be present simultaneously. Understanding this distinction is essential for guiding appropriate investigation and treatment.

Cause of Hair Loss Mechanism Pattern Key Investigations Primary Treatment Expected Recovery
Hypothyroidism (undertreated Hashimoto's) Low T3/T4 causes premature telogen phase; diffuse shedding (telogen effluvium) Diffuse scalp thinning; outer eyebrow loss possible TSH, free T4; recheck 6–8 weeks after dose change Optimise levothyroxine; target TSH 0.4–4.0 mIU/L (NICE NG145) 6–12 months after TSH normalised
Over-replacement with levothyroxine (iatrogenic hyperthyroidism) Suppressed TSH disrupts hair cycle; excess hormone accelerates shedding Diffuse; may accompany palpitations, tremor, heat intolerance TSH, free T4; review levothyroxine dose Reduce levothyroxine dose under GP/endocrinologist supervision Gradual improvement once TSH restabilised
Iron-deficiency / low ferritin Iron required for follicle cell proliferation; deficiency prolongs telogen phase Diffuse; may occur without frank anaemia Full blood count (FBC), serum ferritin Oral iron supplementation (NHS-prescribed); separate from levothyroxine by ≥4 hours Several months after ferritin corrected
Vitamin B12 / folate deficiency Deficiencies more prevalent in autoimmune conditions; impair follicle cell turnover Diffuse; often alongside fatigue, neurological symptoms Serum B12, folate B12 injections or oral supplements; folic acid supplementation (NHS-prescribed) Months after deficiency corrected
Alopecia areata (autoimmune co-morbidity) Separate immune-mediated attack on hair follicles; distinct from thyroid hormone effect Patchy, well-defined bald areas; not diffuse Clinical/dermatological assessment; trichoscopy or scalp biopsy if needed Topical/intralesional corticosteroids; JAK inhibitors (baricitinib, ritlecitinib) for severe cases per NICE TA Variable; specialist-guided
Androgenetic alopecia (coincidental) Androgen-driven follicle miniaturisation; independent of thyroid status Patterned (frontal/crown in women; temples/vertex in men) Dermatological assessment; exclude thyroid and nutritional causes first Topical minoxidil (OTC); dermatology referral if uncertain Ongoing management; not curative
Scarring alopecia (urgent referral needed) Inflammatory destruction of follicles; irreversible if untreated Progressive; scalp pain, erythema, pustules, scaling Urgent/expedited dermatology referral; scalp biopsy Specialist immunosuppressive or anti-inflammatory therapy Early treatment essential to prevent permanent loss

Diagnosing the Cause of Hair Loss in Thyroid Conditions

Diagnosis involves TSH and free T4 blood tests alongside ferritin, full blood count, and vitamin B12 levels; dermatology referral is needed if scarring alopecia or alopecia areata is suspected.

Identifying the precise cause of hair loss in someone with Hashimoto's thyroiditis requires a structured clinical assessment. A GP will typically begin with a detailed history, exploring the pattern and duration of hair loss, any recent physical or emotional stressors, dietary habits, and current medications — all of which can independently contribute to hair shedding. A thorough review of thyroid management history, including recent dose changes or periods of suboptimal control, is equally important.

Blood tests form the cornerstone of investigation. In line with NICE guidance (NG145) and standard NHS practice, the following thyroid function tests are routinely requested:

  • TSH (thyroid-stimulating hormone): The primary screening test; an elevated TSH suggests inadequate thyroid hormone replacement or undertreated hypothyroidism, whilst a suppressed TSH may indicate over-replacement.

  • Free T4 (fT4): Assessed alongside TSH to evaluate the adequacy of levothyroxine therapy. Following any dose change, TSH should be rechecked after six to eight weeks to guide further adjustment.

Additional tests to investigate contributing causes of hair loss — guided by NICE CKS, the Primary Care Dermatology Society (PCDS), and the British Association of Dermatologists (BAD) — may include:

  • Full blood count (FBC): To exclude iron-deficiency anaemia, a common and treatable cause of diffuse hair loss.

  • Serum ferritin: Low ferritin, even in the absence of frank anaemia, is associated with hair shedding.

  • Vitamin B12 and folate: Deficiencies are more prevalent in autoimmune conditions and can contribute to hair loss.

  • Thyroid peroxidase antibodies (TPO-Ab): Useful for confirming the autoimmune aetiology of hypothyroidism where not previously established; routine repeat testing once the diagnosis is confirmed adds limited clinical value.

Adherence to levothyroxine and potential interactions should also be reviewed. Several medicines and supplements — including iron, calcium, and proton pump inhibitors — can impair levothyroxine absorption if taken simultaneously. These should be separated from levothyroxine by at least four hours. Soya-based foods and products may also reduce absorption.

In some cases, a dermatological assessment may be warranted, particularly if the pattern of hair loss suggests alopecia areata or androgenetic alopecia rather than diffuse telogen effluvium. Trichoscopy or scalp biopsy may occasionally be performed in specialist settings. Urgent or expedited dermatology referral should be considered if there are features suggestive of scarring alopecia, such as scalp pain, erythema, pustules, scaling, or rapidly progressive permanent hair loss. Accurate diagnosis is essential, as different causes of hair loss require distinctly different management approaches.

Treatment Options Available on the NHS

Optimising levothyroxine to bring TSH within the target range of 0.4–4.0 mIU/L is the primary treatment; hair regrowth typically takes six to twelve months, and JAK inhibitors are available on the NHS for severe alopecia areata only.

The primary treatment for hair loss related to Hashimoto's thyroiditis is optimising thyroid hormone replacement. Most patients are prescribed levothyroxine, a synthetic form of T4, which the body converts to the active T3. Levothyroxine works by restoring circulating thyroid hormone levels, thereby normalising metabolic function — including the hair growth cycle.

For optimal absorption, levothyroxine should be taken on an empty stomach, at a consistent time each day, and separated from iron or calcium supplements, antacids, and certain other medicines by at least four hours (refer to the BNF or your medicine's patient information leaflet for a full list of interactions). Once TSH levels are brought within the target reference range — typically 0.4–4.0 mIU/L per NICE NG145, though individual targets may vary and should be agreed with your clinician — many patients notice a gradual improvement in hair density over several months. It is important to set realistic expectations, as hair regrowth following telogen effluvium can take six to twelve months even after thyroid levels are well controlled. TSH should be rechecked six to eight weeks after any dose change.

Some patients and clinicians consider adding liothyronine (T3) to levothyroxine therapy. However, NICE NG145 and the British Thyroid Association do not recommend routine use of liothyronine. Any trial of combination T4/T3 therapy should only be considered in exceptional circumstances under the supervision of a consultant endocrinologist, with careful patient selection and monitoring.

Where nutritional deficiencies are identified, supplementation is recommended. Iron supplementation is commonly prescribed for low ferritin, and vitamin B12 injections or oral supplements may be initiated for confirmed deficiency. These are available on the NHS when clinically indicated and can meaningfully support hair recovery when deficiency is a contributing factor. Supplementation beyond correcting confirmed deficiencies has limited evidence for improving hair regrowth.

For hair loss that persists despite optimised thyroid function and corrected nutritional deficiencies, additional NHS options may include:

  • Topical minoxidil: Available over the counter and sometimes recommended for androgenetic alopecia. It is not specifically licensed for thyroid-related hair loss but may be considered in appropriate cases. Refer to the product's patient information leaflet or the BNF for contraindications, cautions, and instructions for use. Suspected side effects should be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

  • Referral to dermatology: For confirmed alopecia areata, treatments such as topical or intralesional corticosteroids, or immunotherapy may be considered within specialist care. JAK inhibitors (such as baricitinib or ritlecitinib) are available on the NHS for severe alopecia areata in eligible patients, subject to the criteria set out in the relevant NICE Technology Appraisals; they are not indicated for thyroid-related telogen effluvium.

The MHRA and EMA have not approved any specific medication solely for thyroid-related hair loss, reinforcing the importance of addressing the underlying hormonal imbalance as the primary therapeutic goal.

Managing Hair Loss Alongside Hashimoto's

Gentle hair care, balanced nutrition, stress management, and consistent levothyroxine adherence support recovery; high-dose biotin supplements should be stopped at least 48 hours before thyroid blood tests due to assay interference.

Living with hair loss can have a significant psychological impact, and this dimension should not be overlooked in the overall management of Hashimoto's thyroiditis. Studies consistently show that hair loss — even when medically considered mild — can affect self-esteem, body image, and quality of life. Patients should feel encouraged to discuss these concerns openly with their healthcare team, as psychological support, including referral to NHS Talking Therapies or signposting to organisations such as Alopecia UK, may be appropriate in some cases.

From a practical standpoint, several self-care strategies can help minimise further hair damage whilst awaiting regrowth:

  • Gentle hair care: Avoid excessive heat styling, tight hairstyles, and harsh chemical treatments, which can exacerbate fragile hair.

  • Balanced nutrition: A diet rich in protein, iron, zinc, and omega-3 fatty acids supports healthy hair follicle function. Crash dieting or very low-calorie intake can worsen telogen effluvium.

  • Stress management: Chronic psychological stress can independently trigger or perpetuate hair shedding. Mindfulness, regular physical activity, and adequate sleep are all beneficial.

  • Medication adherence: Taking levothyroxine consistently — on an empty stomach at a regular time, separated from interacting medicines and supplements by at least four hours — ensures optimal absorption and stable hormone levels.

It is also worth being cautious about biotin supplements, which are widely marketed for hair health. Whilst biotin deficiency is rare, high-dose biotin supplementation can interfere with thyroid function blood tests, potentially producing falsely abnormal TSH and T4 results. The MHRA Drug Safety Update on biotin interference with immunoassays highlights this risk. Patients taking biotin should stop supplementation before blood tests — typically at least 48 hours beforehand, or as advised by their local laboratory — and should inform their GP. There is currently no robust clinical evidence that biotin supplementation meaningfully improves thyroid-related hair loss in individuals who are not deficient. More broadly, taking supplements beyond correcting confirmed deficiencies is unlikely to provide additional benefit for hair regrowth.

When to Seek Further Advice from Your GP or Specialist

See your GP promptly if hair loss is rapid, patchy, or persists despite TSH being within range for six months, or if scalp symptoms such as pain, redness, or pustules suggest scarring alopecia requiring urgent review.

Whilst some degree of hair shedding is expected during periods of suboptimal thyroid control, certain features should prompt a timely review with a GP or specialist. It is important not to dismiss hair loss as an inevitable consequence of Hashimoto's without ensuring that all contributing factors have been properly assessed and addressed.

Contact your GP if you notice any of the following:

  • Hair loss that is rapid, severe, or accompanied by bald patches, which may suggest alopecia areata requiring specialist evaluation.

  • Persistent hair shedding despite TSH levels being within the agreed target range for at least six months.

  • New or worsening symptoms of hypothyroidism — such as fatigue, weight gain, cold intolerance, constipation, or low mood — which may indicate that your levothyroxine dose requires adjustment.

  • Symptoms that may suggest over-replacement or hyperthyroidism — including palpitations, tremor, heat intolerance, unexplained weight loss, or anxiety — as a suppressed TSH can itself cause hair loss and carries other health risks.

  • Signs of nutritional deficiency, including extreme fatigue, pallor, mouth ulcers, or tingling in the hands and feet.

  • Hair loss accompanied by skin changes, nail abnormalities, or joint pain, which could suggest an additional autoimmune condition requiring investigation.

  • Scalp symptoms such as pain, redness, pustules, or scaling, or rapidly progressive hair loss with no regrowth, which may indicate a scarring alopecia requiring urgent dermatology review.

Following any change to your levothyroxine dose, thyroid function should be rechecked after six to eight weeks to confirm that levels are within the appropriate range, in line with NICE NG145.

If your GP suspects a dermatological cause or if hair loss remains unexplained after standard investigations, a referral to a dermatologist or endocrinologist via the NHS may be appropriate. Endocrinologists can review the nuances of thyroid hormone replacement, whilst dermatologists can assess the scalp directly and offer targeted treatments.

Ultimately, hair loss and Hashimoto's thyroiditis are closely linked, but the relationship is multifactorial. With thorough investigation, optimised thyroid management, and appropriate support, most patients can expect meaningful improvement over time. Open communication with your healthcare team remains the most important step in achieving the best possible outcome.

If you experience a suspected side effect from any medicine, please report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions

How long does hair loss from Hashimoto's last before it grows back?

Hair regrowth after thyroid-related shedding typically takes six to twelve months once thyroid hormone levels are well controlled within the target range. Patience is essential, as the hair follicle cycle is slow to recover even after the underlying hormonal imbalance is corrected.

Can my levothyroxine dose be causing my hair loss rather than helping it?

Yes — over-replacement with levothyroxine, resulting in a suppressed TSH, can itself cause diffuse hair shedding alongside symptoms such as palpitations, tremor, or heat intolerance. If you suspect your dose may be too high, ask your GP to check your thyroid function, as TSH should be rechecked six to eight weeks after any dose change.

Is hair loss from Hashimoto's different from alopecia areata?

Yes — Hashimoto's-related hair loss is typically diffuse thinning across the whole scalp, whereas alopecia areata causes distinct patchy bald areas through a separate immune mechanism targeting follicles directly. Both conditions can occur together, so it is important not to assume all hair loss in someone with Hashimoto's is solely thyroid-related.

Should I take biotin supplements to help with hair loss and Hashimoto's?

There is no robust clinical evidence that biotin supplements improve thyroid-related hair loss in people who are not deficient, and high-dose biotin can interfere with thyroid blood tests, producing falsely abnormal TSH and T4 results. If you are taking biotin, stop it at least 48 hours before any thyroid function test and inform your GP.

Can low iron make hair loss worse in people with Hashimoto's?

Low ferritin — even without frank anaemia — is a well-recognised cause of diffuse hair shedding and is more common in people with autoimmune conditions such as Hashimoto's. Your GP can check your ferritin level with a blood test, and iron supplementation is available on the NHS when a deficiency is confirmed.

How do I get a referral to a dermatologist or endocrinologist for hair loss related to Hashimoto's?

Ask your GP for a referral if hair loss persists despite optimised thyroid levels, if the pattern suggests alopecia areata or androgenetic alopecia, or if scalp symptoms such as pain, redness, or pustules raise concern about scarring alopecia. Referrals to NHS dermatology or endocrinology are made through your GP, who will assess which specialist is most appropriate based on your clinical picture.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Book a discovery call

and discuss your eligibility for the Fella Program

Book your free call